Nutriband Inc. (NTRB)

NASDAQ: NTRB · IEX Real-Time Price · USD
3.92
+0.67 (20.62%)
At close: Jun 24, 2022 4:00 PM
3.56
-0.36 (-9.18%)
After-hours: Jun 24, 2022 7:42 PM EDT
20.62%
Market Cap 30.75M
Revenue (ttm) 1.47M
Net Income (ttm) -6.75M
Shares Out 7.84M
EPS (ttm) -0.94
PE Ratio n/a
Forward PE 370.37
Dividend n/a
Ex-Dividend Date n/a
Volume 18,713
Open 3.06
Previous Close 3.25
Day's Range 3.06 - 3.92
52-Week Range 2.81 - 12.32
Beta -0.57
Analysts Buy
Price Target 14.28 (+264.3%)
Earnings Date Jun 27, 2022

About NTRB

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. Nutriband Inc. has a... [Read more...]

Industry Biotechnology
CEO Gareth Sheridan
Employees 13
Stock Exchange NASDAQ
Ticker Symbol NTRB
Full Company Profile

Financial Performance

In 2021, Nutriband's revenue was $1.42 million, an increase of 50.70% compared to the previous year's $943,702. Losses were -$6.18 million, 110.6% more than in 2020.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for NTRB stock is "Buy." The 12-month stock price forecast is 14.28, which is an increase of 264.29% from the latest price.

Price Target
$14.28
(264.29% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Nutriband Supports Update to CDC Opioid Prescribing Guidelines

New proposed guidelines reiterate need for abuse deterrent technologies and call for enabling clinicians to provide comprehensive pain management including appropriate use of opioid medications ORLANDO,...

Nutriband Inc. Interview to Air on Bloomberg U.S. on The Redchip Money Report(R)

ORLANDO, FL / ACCESSWIRE / May 27, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, contract research and development servi...

Nutriband Inc. to Present at the Emerging Growth Conference on May 25

Nutriband Inc. Invites Individual and Institutional Investors As Well as Advisors and Analysts, To Attend Its Real-Time, Interactive Presentation at the Emerging Growth Conference ORLANDO, FL / ACCESSWI...

Nutriband Inc. Receives Orders for $230,000 in Contract Manufacturing for First 3 Weeks of May

ORLANDO, FL / ACCESSWIRE / May 17, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced today it has booked nearly a quarter of a million dollars in new in contract manufacturing orders through i...

Nutriband Subsidiary Active Intelligence LLC Registers with FDA as a Medical Device Manufacturer for its AI Kinesiolo...

Class 1 Medical Device Registration Allows Nutriband To Explore New Product Manufacturing Opportunities Through Its Wholly Owned Subsidiary Active Intelligence LLC ORLANDO, FL / ACCESSWIRE / May 11, 202...

Nutriband Inc. Reports Revenue Up 56% in Fiscal 2022 to a Record $1.4M

ORLANDO, FL / ACCESSWIRE / April 29, 2022 / Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, today announced financial and operational results for the fiscal year ended ...

Nutriband Inc.'s Patent, 'Abuse and Misuse Deterrent Transdermal System' Published by the United States Patent and Tr...

ORLANDO, FL / ACCESSWIRE / February 16, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that the United States Patent and Trademark Office (USPTO) has published its patent titled "Abuse...

Nutriband Issued Full US Patent for Its Aversa(TM) Abuse Deterrent Transdermal Platform by United States Patent and T...

ORLANDO, FL / ACCESSWIRE / January 28, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the receipt of an Issue Notification from the United States Patent and Trademark Office (USPTO) f...

Nutriband Inc. Expands Product Development Pipeline for Its AVERSA(TM) Platform Abuse Deterrent Technology

ORLANDO, FL / ACCESSWIRE / January 18, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) announced an expanded product development pipeline for its proprietary AVERSA™ abuse deterrent transdermal techno...

Nutriband Inc. And Kindeva Drug Delivery Sign Feasibility Agreement to Develop AVERSA(TM) Fentanyl, an Abuse Deterren...

ORLANDO, FL / ACCESSWIRE / January 10, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced the signing of a feasibility agreement with Kindeva Drug Delivery to develop Nutriband's lead pro...

Nutriband Lead Product Aversa(TM) Fentanyl May Reach Peak Annual Sales of $80-200 Million Based on Market Assessment ...

ORLANDO, FL / ACCESSWIRE / January 5, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products has completed the market assessment a...

NTRB Stock Alert: The Patent News Sending Nutriband Soaring

NTRB stock has more than doubled after Nutriband received a patent from South Korea for its transdermal patch tech. The post NTRB Stock Alert: The Patent News Sending Nutriband Soaring appeared first on...

Nutriband stock more than doubles in very active trading after a full patent was issued in South Korea

Shares of Nutriband Inc. NTRB, +117.01% rocketed 126.6% in very active trading Friday morning, after the developer of a fentanyl abuse deterrent patch said it was issued a full patent in South Korea for...

Hot Penny Stocks To Buy Before 2022? 3 Premarket Stocks To Watch

Premarket penny stocks to watch on December 31, 2021. The post Hot Penny Stocks To Buy Before 2022?

Other symbols: LXRXSYTA

Why Nutriband Shares Are Soaring Today

Nutriband Inc (NASDAQ: NTRB) is soaring Friday morning after the company announced the Korean Intellectual Property Office fully issued its patent titled "Abuse and Misuse Deterrent Transdermal System" ...

Nutriband Inc. Issued Full Patent from the Korean Intellectual Property Office for Its "Abuse and Misuse Deterrent Tr...

ORLANDO, FL / ACCESSWIRE / December 31, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced that the Korean Intellectual Property Office (KIPO) has fully issued its patent titled "Abuse and...

Nutriband Inc. Announces $1 Million Share Repurchase Authorization

ORLANDO, FL / ACCESSWIRE / December 29, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), has announced a share repurchase program to buy back up to $1,000,000 of its common stock. As of December 29, 2...

Nutriband Inc. Initiates Plans to Offer Topical Lotion Contract Manufacturing Services

ORLANDO, FL / ACCESSWIRE / December 21, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services, an...

Nutriband Inc. Receives cGMP Certification for Manufacturing Subsidiary

ORLANDO, FL / ACCESSWIRE / December 13, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services, an...

Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021

ORLANDO, FL / ACCESSWIRE / December 3, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services, and...

Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl

ORLANDO, FL / ACCESSWIRE / November 16, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services, an...

Nutriband Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report(R)

ORLANDO, FL / ACCESSWIRE / November 10, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services and...

Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offerin...

ORLANDO, FL / ACCESSWIRE / October 22, 2021 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of pharmaceutical products, contract research and development services, and...

Hot Penny Stocks for Tuesday: Today's 10 Biggest Movers

Penny stocks are on the move Tuesday and we're taking a look at what's hot among traders of the volatile investments today. The post Hot Penny Stocks for Tuesday: Today's 10 Biggest Movers appeared firs...

NTRB Stock: 11 Things for Nutriband Investors to Know About the Covid-19 Antibody Indicator Patch

Nutriband (NTRB) stock is taking off on Tuesday thanks to news that it will be producing Covid-19 antibody check patches. The post NTRB Stock: 11 Things for Nutriband Investors to Know About the Covid-1...